A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects with Relapsed/Refractory Follicular Lymphoma
ENROLLING
Trial ID:
NCT05371093 Protocol # :
22-271
Phase
III
Disease Sites
Non-Hodgkin's Lymphoma
Principal Investigator
Jacobson, Caron, A
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-271
22-271